A therapeutic effective case of bronchial arterial infusion of fine-powder cisplatin (IA-call^|^reg;) for pulmonary metastases originated from hepatocellular carcinoma

準一, 古山; 竜太郎, 森園; 哲, 後藤; 康太郎, 森田; 仁, 西尾; 秀雄, 高木; 政英, 内沢; 仁志, 水尾

doi:10.2957/kanzo.54.19

Search citation statements

Order By: Relevance

Paper Sections

Select...

Discussion1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2014

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

(1 citation statement)

References 9 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…On the other hand, BAI is often used to treat metastatic lung cancer, with dramatic effects (21,22). Table provides a summary of successful cases, including the present case, of treatment with BAI for lung metastasis of HCC (23)(24)(25)(26)(27)(28). Five patients were treated with BAI only because the primary HCCs were well controlled.…”

Section: Discussionmentioning

confidence: 99%

Successful Treatment of Hepatocellular Carcinoma with Lung Metastasis Using Hepatic and Bronchial Artery Infusion Chemotherapy

et al. 2014

View full text Add to dashboard Cite

We herein report a case of hepatocellular carcinoma (HCC) with lung metastasis that was successfully treated with transcatheter arterial infusion chemotherapy via the hepatic and bronchial arteries. A 64-year-old man diagnosed with HCC in 2003 was treated with locoregional therapy followed by sorafenib for recurrent HCC. Tumor thrombosis and lung metastasis were noted in April 2012. We administered IA-call , a finepowder formulation of cisplatin, via the hepatic and bronchial arteries. This therapy resulted in the disappearance of the lung metastases and a partial response to tumor thrombosis. The patient remained alive for 23 months after developing lung metastasis.

show abstract

Section: Discussionmentioning

confidence: 99%